Esta tradução está a ser preparada. Entretanto, mostramos temporariamente a versão original em inglês.
Negócios · 24/02/20101 min de leitura
Pulmonary-Allergy Drugs Advisory Committee; Amendment of Notice
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA) is announcing an amendment to the notice of a meeting of the Pulmonary-Allergy Drugs Advisory Committee. This meeting was announced in the Federal Register of February 2, 2010 (75 FR 5334). The amendment is being made to reflect a change in the Name of Committee portion of the document. There are no other changes.
Idioma original da fonte: Federal Register — Health and Human ServicesAbrir o comunicado original →